Previous post Next post

Covid: Israel’s vaccine experiment looks promising


Israel leads the world in the race to vaccinate against the SARS-CoV-2 virus, in what some are calling the world’s leading Covid-19 vaccine experiment. 64 doses of vaccine per 100 people have been administered there, far more than in any other nation.

Israel’s strategy has focused on protecting the most vulnerable first. By 6 February 2021, 80% of the population over 60 had been vaccinated, compared to less than half that percentage among those under 60 – see chart below.

These significantly different vaccination rates among different age groups offer a glimpse of what vaccines can achieve against the virus.


Since 20 December 2020, when Israel began vaccinating, severe Covid-19 hospital admissions have more than doubled among those under 60, who were not prioritised for vaccination. However, among those over 60, who were first in line for jabs, severe hospital admissions have risen by less than 50%, less than half the rate of those under 60, despite their greater average vulnerability.

Оrange line 0-59 years old, Blue line 60+

Vaccination in Israel appears to be keeping people out of hospital – see chart above. The hospitalisation difference between the different age groups was even greater in cities where vaccination programmes are more advanced.

Switzerland has a long way to go to catch up with Israel. Latest data show Switzerland has administered 369,085 doses of vaccine, a rate of 4 per 100, far behind Israel’s rate of 64 per 100.

The Israeli study is based on individuals who have had the BioNTech vaccine (BNT162b2).

Covid: Israel’s vaccine experiment looks promising



Full story here Are you the author?
About Le News
Le News
The newspaper Le News is a free, quality, local English language newspaper launched on 31 October 2013. Le News fills a gap in local Swiss media for the numerous English-speakers living and visiting Switzerland. In late January 2015 we decided to put our print medium on hold and focus on our digital media presence.
Previous post See more for 3) Swiss Markets and News Next post
Tags: ,,,

Permanent link to this article:

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

This site uses Akismet to reduce spam. Learn how your comment data is processed.